CMSA, is a wholly owned subsidiary of Cipla, and is the holding company for the group operations in South Africa. The group is involved in the manufacturing, marketing, and supply of pharmaceutical products.
The investment will be utilised to reduce inter-group debt and improve the capital structure of CMSA and its subsidiaries.